A Defense of PGS
An article recently published in The Cut column of New York Magazine has captured the attention of the fertility and genetic testing community. Titled “A New Last Chance”, the article questioned the utility of preimplantation genetic screening (PGS) – a technique which data from the CDC and SART, along with the results of several randomized controlled trials (RCTs), have all …